NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 09/04/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization113.27 mln
Float7.12 mln
Earnings Date09/02/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.52
Likely reliable
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.10
Very low leverage
Pre-Tax Margin
-11%
Loss-making
ROE
-10.92
Negative
Business Description
Burning Rock Biotech, founded in 2014 and based in Guangzhou, China, develops advanced genetic testing tools that help doctors choose the right cancer treatments for their patients. The company serves hospitals, independent laboratories, and pharmaceutical companies across China and the United States, offering tests that analyze tumor DNA from both tissue and blood samples across a wide range of cancer types. It also partners with major global pharmaceutical companies to support clinical trials and drug development research.
